Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
MEMBRANE POTENTIAL | > 200 µM | 30 mins | mouse | liver mitochondria | Rh123 fluorescence (excitation 485 nm, emission 535 nm) are recorded using a fluorescence multi-well plate reader (mCICCP (20 µM) treatments was considered as the 100% baseline for ΔΨm loss) | decrease | EC20 | 36 |
RESPIRATION | 29.6 µM | 60 mins | mouse | liver mitochondria | Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. | decrease | EC20 | 36 |
RESPIRATION | ND | 60 mins | mouse | liver mitochondria | Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. | Negative | EC20 | 36 |
SWELLING | > 200 µM | 30 mins | mouse | liver mitochondria | swelling assay: Absorbance at 545 nm using a fluorescence multi-well plate reader (CaCl2 (50 µM) was considered as the 100% baseline for the swelling ) | increase | EC20 | 36 |
Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
NADH:ubiquinone reductase | 29.6 µM | 60 mins | mouse | liver mitochondria | Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Rotenone (2µM) was used as 100% baseline for complex I inhibition. | inhibit | EC20 | 36 |
Succinate dehydrogenase | ND | 60 mins | mouse | liver mitochondria | Oxygen consumption was monitored with 50nM MitoXpress ( an oxygen-sensitive phosphorescent dye) using a spectrofluorimeter (Tecan Infinite 200; λExcitation 380nm; λEmission 650nm). Oligomycin A (1µM) was used as 100% baseline for complex II inhibition. | Negative | EC20 | 36 |
Cytochrome c | > 200 µM | 30 mins | mouse | liver mitochondria | Cytochrome c release was evaluated using ELISA kit ( 20 µg/ml Alamethicin was used as 100% baseline) | release | EC20 | 36 |
(2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one | (E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one | (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one |
(E)-2',3,4,4'-terahydroxychalcone | (E)-3-(3,4-Dihydroxy-phenyl)-1-(2,4-dihydroxy-phenyl)-propenone | 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one |
2 inverted exclamation mark ,3,4,4 inverted exclamation mark -tetrahydroxy Chalcone | 2′,4′,3,4-Tetrahydroxychalcone | 2',3,4,4'-Tetrahydroxychalcone |
2',3,4,4'-Tetrahydroxychalcone | 2',4',3,4-Tetrahydroxychalcone | 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)- |
2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)- | 2-Propen-1-one,1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)- | 21849-70-7 |
3,4,2'',4''-tetrahydroxychalone | 3,4,2',4'-Tetrahydroxychalcone | 3,4,2',4'-Tetrahydroxychalone |
3-(3,4-Dihydroxy-phenyl)-1-(2,4-dihydroxy-phenyl)-propenone | 487-52-5 | 4WVS5M0LGF |
ACM21849707 | AKOS032948361 | AS-35311 |
Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihydroxyphenyl)- | B3803 | BDBM50042949 |
BRD-K17497770-001-01-0 | Butein | Butein, analytical standard |
Butein, solid | C08578 | CCG-208298 |
CHEBI:3237 | CHEBI:92312 | CHEMBL128000 |
CS-5675 | Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI) | EINECS 207-659-5 |
HSCI1_000162 | HY-16558 | LMPK12120111 |
LS-123867 | LS-175098 | NCGC00163519-01 |
NS00018353 | NSC-652892 | NSC652892 |
Q5002498 | SCHEMBL139243 | SR-05000002316 |
SR-05000002316-2 | ST50331397 | SW219249-1 |
UNII-4WVS5M0LGF | W1236 | ZINC12428433 |
butein | s8036 |
CAS Number | 21849-70-7, 487-52-5 |
PubChem Compound | 5281222 |